Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-Up Study to Assess Long-Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

NCT02292784 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02292784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02292784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-Up Study to Assess Long-Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
June 1, 2015
Completion date
September 2, 2019
Enrollment
98 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

obstetric labour, premature